Gregory P Takacs

Gregory P Takacs,

GRADUATE RES AST

Department: MD-PHARMACOLOGY / THERAPEUTICS
Business Phone: (352) 294-5351
Business Email: gtakacs@ufl.edu

Publications

2024
DR5 disulfide bonding as a sensor and effector of protein folding stress.
bioRxiv : the preprint server for biology. [DOI] 10.1101/2024.03.04.583390. [PMID] 38496520.
2023
Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma.
bioRxiv : the preprint server for biology. [DOI] 10.1101/2023.05.15.540846. [PMID] 37292799.
2023
Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma.
Journal of mathematical biology. 88(1) [DOI] 10.1007/s00285-023-02027-y. [PMID] 38099947.
2022
Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+/CX3CR1+ M-MDSCs into the tumor microenvironment in a redundant manner.
Frontiers in immunology. 13 [DOI] 10.3389/fimmu.2022.993444. [PMID] 36685592.
2021
Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy.
Pharmacology & therapeutics. 222 [DOI] 10.1016/j.pharmthera.2020.107790. [PMID] 33316289.
2020
Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid Leukemia.
Cancers. 12(12) [DOI] 10.3390/cancers12123710. [PMID] 33321907.

Contact Details

Phones:
Business:
(352) 294-5351
Emails:
Business:
gtakacs@ufl.edu
Addresses:
Business Mailing:
PO Box 100267
GAINESVILLE FL 32610
Business Street:
ARB 5-234
1200 Newell Drive
GAINESVILLE FL 32610